Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CYCS pseudogene 35 (CYCSP35) is a processed pseudogene of the gene encoding cytochrome c, a mitochondrial electron carrier involved in apoptosis and cellular respiration. As a pseudogene, CYCSP35 is a non-functional sequence that originated from retrotransposition or duplication of the functional CYCS gene. There is no evidence that CYCSP35 expresses a protein or has any known biological, pathological, or pharmacological role; therefore, it is not considered a therapeutic target[3][2]. Pseudogenes like CYCSP35 are common in the human genome and generally do not contribute to normal physiology or disease beyond serving as genomic relics of gene duplication or retrotransposition events. Note: - This entry is distinct from the parental CYCS gene, which encodes cytochrome c—the small heme protein central to mitochondrial electron transport and apoptosis[2][4]. - The alternative names HCP35 and HC8 are aliases for this specific pseudogene entry, not for the parent functional gene. If you intended to inquire about the functional CYCS protein or its role, please specify "CYCS" (cytochrome c, somatic).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CYCS pseudogene 35 (CYCSP35).